欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/0506/002
药品名称Inspra 50
活性成分
    • eplerenone 50.0 mg
剂型Film-coated tablet
上市许可持有人Pfizer B.V. Rivium Westlaan 142 P.O. box 37 2900 AA Capelle a/d IJssel
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Spain (ES)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Inspra 50 mg - Filmtabletten
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Inspra
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
    • Slovakia (SK)
      INSPRA 50 mg filmom obalené tablety
    • Slovenia (SI)
    • Malta (MT)
    • Ireland (IE)
许可日期2004/08/05
最近更新日期2024/04/22
药物ATC编码
    • C03DA04 eplerenone
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase